University of Washington Arboviral Research Network (UWARN)
华盛顿大学虫媒病毒研究网络 (UWARN)
基本信息
- 批准号:10687434
- 负责人:
- 金额:$ 116.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-16 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdministrative CoordinationAlphavirusAnimalsAntibodiesArbovirus InfectionsArbovirusesAreaArthropod VectorsBackBacteriologyBindingBiological AssayBiological MarkersBloodBody FluidsBrazilCell SeparationChikungunya virusClinicalClinical ManagementClinical TrialsCollaborationsCollectionCongoContainmentDataDengueDengue InfectionDengue VirusDetectionDevelopmentDiagnosisDiagnosticDiagnostic ReagentDiseaseEmergency SituationEmerging Communicable DiseasesEngineeringEnzyme-Linked Immunosorbent AssayEpitopesFar EastFeverFlavivirusFluorescenceFreezingFutureGenomic approachHumanImmune responseImmune systemImmunoglobulin GIndividualInfectionInfectious Diseases ResearchInnate Immune ResponseInnate Immune SystemInstitutesInstitutionInternationalInterventionInvestigationJapanese EncephalitisKnowledgeLaboratoriesLaboratory ResearchLeadLightLogisticsMeasurementMetagenomicsMicrocephalyMolecularMonitorMonoclonal AntibodiesNatural ImmunityOropouche virusOrthobunyavirusOutcomePakistanParasitic infectionPathogenesisPathway interactionsPatientsPopulationPrevalenceProcessProductionProtein EngineeringProteinsReadinessReagentResearchResourcesRift Valley FeverRiskSamplingSenegalSensitivity and SpecificitySerologySeroprevalencesSiteSouth AfricaSouth AmericaSpecimenStatistical Data InterpretationSystemTaiwanTechnologyTechnology TransferTestingThe science of MycologyTherapeuticTimeUniversitiesVaccinesVariantVeterinariansViralViral AntibodiesViral Hemorrhagic FeversViral Load resultVirusVirus DiseasesWashingtonYellow FeverZIKAZika Virusantagonistarthropod-bornebasebiobankcandidate markerchikungunyacohortcross reactivitydata managementdesignexperienceglobal healthglobal health emergencyhuman monoclonal antibodiesimprovedimproved outcomeinnovationneutralizing antibodyneutralizing monoclonal antibodiesnext generation sequencingnovelnovel diagnosticsnovel strategiespandemic diseasepandemic preparednesspathogenpathogenic viruspoint of carepopulation basedprospectivesevere denguetherapeutic targettranscriptomicsviral detectionvirologyvirus host interaction
项目摘要
Abstract: University of Washington Arboviral Research Network (UWARN)
The University of Washington Arboviral Research Network (UWARN) will address emerging and re-emerging
infectious diseases by carrying out research on arboviruses that include current high burden pathogens including
dengue, chikungunya, and Zika viruses. Arboviruses also include emerging and re-emerging viruses such as
Mayaro, Una, Usutu, Japanese encephalitis, yellow fever, Crimean-Congo hemorrhagic fever, and Oropouche
viruses. UWARN will leverage the UW Metacenter for Pandemic Disease Preparedness and strong research
laboratory partners in Brazil, Senegal, South Africa, Pakistan and Taiwan as well as the UW Department of
Global Health global reach in capacity building. The UWARN international Collaborating Partners have
institution-based and population-based cohorts in place to carry out the planned research and monitor for new
virus emergence. The proposed UWARN research will create new human viral-neutralizing monoclonal
antibodies (Hu-nMabs) that can be used as therapeutics or diagnostics. UWARN research will also create new
diagnostics, created ab initio by the Institute for Protein Design, as artificial proteins that release light when
antibodies to virus are present in body fluids. Finally, UWARN research will generate an understanding of how
viruses manipulate the human innate immune system, and this information will be used to design biomarkers to
predict severe disease as well as to suggest host-directed therapies that could lead to better outcomes after
arboviral infection. The proposed technologies are generic and could be rapidly adapted to any future emerging
arbovirus threat. UWARN collaborators span virology, bacteriology, mycology, and parasitic infections, such that
UWARN can respond to diverse emerging infectious diseases threats. UWARN international laboratories have
advanced capabilities including biorepositories with generator-power backed-up -80C freezers, next-generation
sequencing (NGS) capabilities, fluorescence cell sorting, and BSL-3 containment facilities. UWARN cohorts have
biobanked samples taken from individuals during acute febrile illnesses, with known and unknown arboviral
diseases, and partnership sites are poised for prospective collection of population and facility–based samples.
UWARN labs will use metagenomic NGS to detect novel viral emergence in affiliated cohorts. UWARN Partners
have collaborating entomologists and veterinarians to sample arthropod vectors and animal reservoirs as
needed. Additional innovative capacity included the Brazil UWARN partner’s mobile van with on board NGS
capability for real-time, on-site viral sequencing and sampling to viral identification in less than 18 hrs. A second
partner, IRESSEF in Senegal, plans to set up a similar mobile vehicle for viral sampling and sequencing in
Senegal and the Brazil group will collaborate with IRESSEF on technology transfer and best practices. UWARN
partners will serve as a resource to other Emerging Infectious Diseases Research Centers (EIDRC) providing
expertise in monoclonal antibodies, protein design, and host directed therapies.
摘要:华盛顿大学虫媒病毒研究网络(UWARN)
华盛顿大学虫媒病毒研究网络(UWARN)将致力于解决新兴和重新出现的虫媒病毒问题
通过对包括当前高负荷病原体在内的虫媒病毒进行研究来预防传染病
登革热、基孔肯雅热和寨卡病毒。虫媒病毒还包括新出现和重新出现的病毒,例如
马亚罗病、乌纳病、乌苏图病、日本脑炎、黄热病、克里米亚-刚果出血热和奥罗普切病
病毒。 UWARN 将利用威斯康辛大学元中心进行流行病防范和强有力的研究
巴西、塞内加尔、南非、巴基斯坦和台湾的实验室合作伙伴以及威斯康星大学
全球卫生在能力建设方面的全球影响力。 UWARN 国际合作伙伴有
以机构和人口为基础的队列到位,以开展计划的研究和监测新的
病毒的出现。拟议的 UWARN 研究将创造新的人类病毒中和单克隆抗体
可用作治疗或诊断的抗体(Hu-nMab)。 UWARN研究也将创造新的
诊断,由蛋白质设计研究所从头开始创建,作为人造蛋白质,当
体液中存在病毒抗体。最后,UWARN 研究将了解如何
病毒操纵人类先天免疫系统,这些信息将用于设计生物标志物
预测严重疾病并建议针对宿主的治疗,这些治疗可能会在治疗后带来更好的结果
虫媒病毒感染。所提出的技术是通用的,可以快速适应任何未来的新兴技术
虫媒病毒威胁。 UWARN 的合作者涵盖病毒学、细菌学、真菌学和寄生虫感染领域,因此
UWARN 可以应对各种新出现的传染病威胁。 UWARN国际实验室有
先进的功能,包括配备发电机备用 -80C 冰箱的生物样本库、下一代
测序 (NGS) 功能、荧光细胞分选和 BSL-3 防护设施。 UWARN 队列有
生物库样本取自急性发热性疾病期间的个体,其中含有已知和未知的虫媒病毒
疾病和合作伙伴站点已准备好前瞻性地收集人口和设施样本。
UWARN 实验室将使用宏基因组 NGS 来检测附属队列中新病毒的出现。优警告合作伙伴
与昆虫学家和兽医合作,对节肢动物媒介和动物宿主进行采样
需要。其他创新能力包括巴西 UWARN 合作伙伴配备 NGS 的移动货车
能够在 18 小时内进行实时现场病毒测序和采样以进行病毒鉴定。一秒钟
塞内加尔的合作伙伴 IRESSEF 计划在塞内加尔建立一个类似的移动车辆,用于病毒采样和测序
塞内加尔和巴西集团将与 IRESSEF 在技术转让和最佳实践方面进行合作。警告
合作伙伴将作为其他新发传染病研究中心 (EIDRC) 的资源,提供
单克隆抗体、蛋白质设计和宿主定向疗法方面的专业知识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Gale其他文献
Michael Gale的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Gale', 18)}}的其他基金
Project 2: Systems biology analyses of RHCMV/SIV and IL-15 mechanisms of immune programming
项目2:RHCMV/SIV和IL-15免疫编程机制的系统生物学分析
- 批准号:
10723640 - 财政年份:2023
- 资助金额:
$ 116.6万 - 项目类别:
MECHANISMS PROGRAMMING PROTECTIVE IMMUNITY FROM RhCMV-SIV VACCINE AND IL-15 ACTIONS
RhCMV-SIV 疫苗和 IL-15 作用的保护性免疫编程机制
- 批准号:
10723635 - 财政年份:2023
- 资助金额:
$ 116.6万 - 项目类别:
Omics, Bioinformatics, and Data Management Core
组学、生物信息学和数据管理核心
- 批准号:
10709011 - 财政年份:2022
- 资助金额:
$ 116.6万 - 项目类别:
Omics, Bioinformatics, and Data Management Core
组学、生物信息学和数据管理核心
- 批准号:
10619301 - 财政年份:2022
- 资助金额:
$ 116.6万 - 项目类别:
University of Washington Arboviral Research Network (UWARN)
华盛顿大学虫媒病毒研究网络 (UWARN)
- 批准号:
10493552 - 财政年份:2021
- 资助金额:
$ 116.6万 - 项目类别:
Host inflammatory response to SARS-CoV-2
宿主对 SARS-CoV-2 的炎症反应
- 批准号:
10192439 - 财政年份:2021
- 资助金额:
$ 116.6万 - 项目类别:
University of Washington Arboviral Research Network (UWARN)
华盛顿大学虫媒病毒研究网络 (UWARN)
- 批准号:
10770598 - 财政年份:2020
- 资助金额:
$ 116.6万 - 项目类别:
University of Washington Arboviral Research Network (UWARN)
华盛顿大学虫媒病毒研究网络 (UWARN)
- 批准号:
10170249 - 财政年份:2020
- 资助金额:
$ 116.6万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 116.6万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 116.6万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 116.6万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 116.6万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 116.6万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 116.6万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 116.6万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 116.6万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 116.6万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 116.6万 - 项目类别:
Research Grant














{{item.name}}会员




